IDEXX LABORATORIES INC /DE Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Idexx Laboratories Inc /De quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • Idexx Laboratories Inc /De Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $212M, a 46.6% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $212M +$67.3M +46.6% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $144M +$21.9M +17.8% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $123M +$30K +0.02% Dec 31, 2021 10-K 2023-02-16
Q4 2020 $123M +$65.5M +115% Dec 31, 2020 10-K 2022-02-16
Q4 2019 $57.1M +$2.34M +4.28% Dec 31, 2019 10-K 2021-02-12
Q4 2018 $54.7M +$5.72M +11.7% Dec 31, 2018 10-K 2020-02-14
Q4 2017 $49M -$7.75M -13.7% Dec 31, 2017 10-K 2019-02-15
Q4 2016 $56.7M Dec 31, 2016 10-K 2018-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.